Platform for End-of-life Awareness, Conversations, and Education (PEACE) Among Registered Nurses

August 17, 2026 updated by: Ang Wei How Darryl, National University of Singapore

Platform for End-of-life Awareness, Conversations, and Education (PEACE) Among Registered Nurses: A Mixed Methods Study

The goal of this clinical trial is to evaluate whether the PEACE program can improve early career registered nurses' registered nurses' attitudes towards caring for palliative patients, ability to cope with patients' death, and self-efficacy in initiating advanced care planning conversations

This study aims to address the following research questions:

  • Does the PEACE program improve early career registered nurses' attitudes towards caring for palliative patients, ability to cope with patients' death and self-efficacy in initiating advanced care planning conversations?
  • What are the participants' experiences of participating in the PEACE program?

Researchers will compare participants who receive the PEACE program (death conversation and online ACP education) with participants who receive only the online ACP education to see if informal death conversations improve early career registered nurses' attitudes towards caring for palliative patients, ability to cope with patients' death and self-efficacy in initiating advanced care planning conversations.

Participants will:

  • Complete online questionnaires measuring attitudes towards caring for palliative patients, ability to cope with patients' death and self-efficacy in initiating advanced care planning conversations.
  • Participate in a facilitator-led group discussion session about experiences of patients' deaths, coping with patients' death and dying, communications with patients and/or family members about death and dying, and discussing advance care planning with patients and/or family members (intervention group only).
  • Complete an asynchronous online ACP education session consisting of short recorded videos and an online discussion forum (both intervention and control group).
  • Complete follow-up surveys, including a 3-month follow-up assessing whether participants have engage with any patients and/or their family members in advance care planning conversations.

Study Overview

Status

Not yet recruiting

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Estimated)

150

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

  • Singapore
      • Singapore, Singapore
        • National University of Singapore
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Registered nurses within the first five years of practice
  • Between the ages of 21 to 65 years
  • Currently working in a healthcare setting in SIngapore

Exclusion Criteria:

  • Participated in a similar death conversation program
  • Received training in Advance Care Planning or Serious Illness Conversations
  • Any self-reported history of mental health disorders (e.g., depression), or neurological disorders (e.g., brain tumors)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Intervention Group - on site group discussions + online learning session

Participants in this arm will receive the two-session PEACE Program.

Session 1 is an on site, facilitator-led group discussion lasting 2 hours, covering:

  1. Experiences of death and dying
  2. Coping with death and dying.
  3. Communication about death and dying
  4. Discussing Advance Care Planning (ACP).

Session 2 is an online asynchronous learning session with short videos on ACP with discussion forums.
Behavioral: Online ACP Education
An online asynchronous learning session with short videos on ACP with discussion forums.
Behavioral: Death Conversation
On site, facilitator-led group discussion lasting 2 hours, covering: 1) Experiences of patients' deaths; 2) Coping with patients' death and dying; 3) Communication with patients and/or family members about death and dying; 4) Discussing advance care planning with patients and/or family members
Active Comparator: Control Group - Only online learning session
Participants in this arm will only receive the online ACP education component, identical to Session 2 of the PEACE programme. No facilitator-led group discussions are provided.
Behavioral: Online ACP Education
An online asynchronous learning session with short videos on ACP with discussion forums.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Frommelt Attitude Toward Care of the Dying Scale
Time Frame: Baseline
A 30-item 5 point Likert scale. Positive items are scored one (strongly disagree) to five (strongly agree). Scores are reversed for negative items. Possible scores can range from 30-150. A higher score indicates a more positive attitude toward caring for this patient population.
Baseline
Frommelt Attitude Toward Care of the Dying Scale
Time Frame: Post-test (Immediately at end of 2-weeks intervention)
A 30-item 5 point Likert scale. Positive items are scored one (strongly disagree) to five (strongly agree). Scores are reversed for negative items. Possible scores can range from 30-150. A higher score indicates a more positive attitude toward caring for this patient population.
Post-test (Immediately at end of 2-weeks intervention)
Frommelt Attitude Toward Care of the Dying Scale
Time Frame: 3 months follow-up
A 30-item 5 point Likert scale. Positive items are scored one (strongly disagree) to five (strongly agree). Scores are reversed for negative items. Possible scores can range from 30-150. A higher score indicates a more positive attitude toward caring for this patient population.
3 months follow-up

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Palliative care self-efficacy scale
Time Frame: Baseline
A twelve item 4-point Likert scale, scored from 1 (Need further basic instruction) to 4 (Confident to perform independently). Higher scores indicate nurses having higher degree of confidence with the respective patient/family interactions and patient management topics.
Baseline
Palliative care self-efficacy scale
Time Frame: Post-test (Immediately at end of 2-weeks intervention)
A twelve item 4-point Likert scale, scored from 1 (Need further basic instruction) to 4 (Confident to perform independently). Higher scores indicate nurses having higher degree of confidence with the respective patient/family interactions and patient management topics.
Post-test (Immediately at end of 2-weeks intervention)
Palliative care self-efficacy scale
Time Frame: 3 months follow-up
A twelve item 4-point Likert scale, scored from 1 (Need further basic instruction) to 4 (Confident to perform independently). Higher scores indicate nurses having higher degree of confidence with the respective patient/family interactions and patient management topics.
3 months follow-up
Advance Care Planning Self-Efficacy (ACP-SE) Scale
Time Frame: Baseline
An 18-item 5-point Likert scale, scored from 1 (Not at all confident) to 5 (Very confident), with higher scores indicating more confidence in performing respective tasks regarding Advance Care Planning (ACP) conversations for patients.
Baseline
Advance Care Planning Self-Efficacy (ACP-SE) Scale
Time Frame: Post-test (Immediately at end of 2-weeks intervention)
An 18-item 5-point Likert scale, scored from 1 (Not at all confident) to 5 (Very confident), with higher scores indicating more confidence in performing respective tasks regarding Advance Care Planning (ACP) conversations for patients.
Post-test (Immediately at end of 2-weeks intervention)
Advance Care Planning Self-Efficacy (ACP-SE) Scale
Time Frame: 3 months follow-up
An 18-item 5-point Likert scale, scored from 1 (Not at all confident) to 5 (Very confident), with higher scores indicating more confidence in performing respective tasks regarding Advance Care Planning (ACP) conversations for patients.
3 months follow-up
End-of-life planning conversations
Time Frame: 3 months follow-up
Self-reported number of conversations held with patients regarding Advance Care Planning
3 months follow-up

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

National University of Singapore

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

September 1, 2026

Primary Completion (Estimated)

December 31, 2027

Study Completion (Estimated)

December 31, 2027

Study Registration Dates

First Submitted

August 11, 2026

First Submitted That Met QC Criteria

August 17, 2026

First Posted (Actual)

August 19, 2026

Study Record Updates

Last Update Posted (Actual)

August 19, 2026

Last Update Submitted That Met QC Criteria

August 17, 2026

Last Verified

August 1, 2026

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • NUS-DERC-001647
  • A-0010425-00-00 (Other Grant/Funding Number: National University of Singapore)

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe